IHCNF:OTC-iShares VII Public Limited Company - iShares MSCI Canada UCITS ETF (USD)

ETF | Others |

Last Closing

USD 214.5995

Change

0.00 (0.00)%

Market Cap

N/A

Volume

161.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

-9.95 (-1.53%)

USD 32.85B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
EBCRY EBCRY

N/A

USD 4.61B
ETHE Grayscale Ethereum Trust (ETH)

-1.04 (-4.52%)

USD 3.43B
SSEEF SSgA SPDR ETFs Europe I Public..

N/A

USD 2.95B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B
ISRPF iShares Public Limited Company..

N/A

USD 2.22B

ETFs Containing IHCNF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.77% 70% C- 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.77% 70% C- 54% F
Trailing 12 Months  
Capital Gain 18.42% 73% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.42% 71% C- 68% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.70% 57% F 50% F
Dividend Return 7.70% 56% F 46% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.53% 60% D- 93% A
Risk Adjusted Return 52.99% 66% D+ 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike